blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3587449

EP3587449 - PREVENTION OF INFECTION [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  25.06.2021
Database last updated on 14.09.2024
FormerExamination is in progress
Status updated on  20.08.2020
FormerRequest for examination was made
Status updated on  03.07.2020
FormerThe application has been published
Status updated on  05.12.2019
Most recent event   Tooltip25.06.2021Application deemed to be withdrawnpublished on 28.07.2021  [2021/30]
Applicant(s)For all designated states
CSL Behring AG
Wankdorfstrasse 10
3014 Bern / CH
For all designated states
Beth Israel Deaconess Medical Center, Inc.
330 Brookline Avenue
Boston, MA 02215 / US
[2020/01]
Inventor(s)01 / Kelly, Ciaran
308 Prince Street
West Newton, MA 02465 / US
02 / Chen, Xinhua
260 Main Street No. 102
Malden, MA 02215 / US
03 / Miescher, Sylvia
Hintere Engehaldenstrasse 76
3004 Bern / CH
04 / Spycher, Martin
Rosengasse 22
3250 Lyss / CH
05 / Wymann, Sandra
Innerer Giessenweg 4
3110 Muensingen / CH
06 / Zuercher, Adrian
Stapfenackerstrasse 95
3018 Bern / CH
 [2020/16]
Former [2020/01]01 / Kelly, Ciaran
308 Prince Street
West Newton, MA 02465 / US
02 / Chen, Xinhua
260 Main Street No. 102
Malden, MA 02215 / US
03 / Miescher, Sylvia
Hintere Engehaldenstrasse 76
3004 Bern / CH
04 / Spycher, Martin
Rosengasse 22
3250 Lyss / CH
05 / Wymann, Sandra
Stauffacherstrasse 30
3014 Bern / CH
06 / Zuercher, Adrian
Stapfenackerstrasse 95
3018 Bern / CH
Representative(s)Peter, Beate, et al
CSL Behring GmbH
Patents & Licenses
Emil-von-Behring-Straße 76
35041 Marburg / DE
[2020/01]
Application number, filing date19187317.308.03.2013
[2020/01]
Priority number, dateEP2012015893309.03.2012         Original published format: EP 12158933
[2020/01]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3587449
Date:01.01.2020
Language:EN
[2020/01]
Search report(s)(Supplementary) European search report - dispatched on:EP22.11.2019
ClassificationIPC:C07K16/12, A61K38/14, A61K39/40, A61P31/04
[2020/01]
CPC:
C07K16/1282 (EP,US); A61K38/14 (EP,US); A61K38/1774 (EP,US);
A61K39/395 (EP,US); A61K39/40 (EP,US); A61K45/06 (EP,US);
A61P31/04 (EP); A61K2039/505 (US); C07K2317/21 (EP,US) (-)
C-Set:
A61K39/395, A61K2300/00 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/32]
Former [2020/01]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:PRÄVENTION VON INFEKTIONEN[2020/01]
English:PREVENTION OF INFECTION[2020/01]
French:PRÉVENTION DES INFECTIONS[2020/01]
Examination procedure01.07.2020Amendment by applicant (claims and/or description)
01.07.2020Examination requested  [2020/32]
01.07.2020Date on which the examining division has become responsible
19.08.2020Despatch of a communication from the examining division (Time limit: M06)
02.03.2021Application deemed to be withdrawn, date of legal effect  [2021/30]
25.03.2021Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2021/30]
Parent application(s)   TooltipEP13708787.0  / EP2822969
Fees paidRenewal fee
19.11.2019Renewal fee patent year 03
19.11.2019Renewal fee patent year 04
19.11.2019Renewal fee patent year 05
19.11.2019Renewal fee patent year 06
19.11.2019Renewal fee patent year 07
31.03.2020Renewal fee patent year 08
Penalty fee
Additional fee for renewal fee
31.03.202109   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]US2008145420  (SIMON MICHAEL R [US]) [A] 1-23;
 [XY]US2008260822  (SIMON MICHAEL R [US], et al) [X] 1-7,11-17,19-23 * paragraphs [0007] , [0 15] , [0 48] , [0 50]; claims 15, 18, 20 * [Y] 8-10,18;
 [A]  - PHALIPON A ET AL, "Novel functions of the polymeric Ig receptor: well beyond transport of immunoglobulins", TRENDS IN IMMUNOLOGY, ELSEVIER, RAHWAY, NJ, US, (20030201), vol. 24, no. 2, doi:10.1016/S1471-4906(02)00031-5, ISSN 1471-4906, pages 55 - 58, XP004402384 [A] 1-23 * the whole document *

DOI:   http://dx.doi.org/10.1016/S1471-4906(02)00031-5
 [Y]  - DALLAS S D ET AL, "Binding of Clostridium difficile toxin A to human milk secretory component", JOURNAL OF MEDICAL MICROBIOLOGY, (199810), vol. 47, no. 10, ISSN 0022-2615, pages 879 - 888, XP002681824 [Y] 1-23 * pages 884, 885, column left *

DOI:   http://dx.doi.org/10.1099/00222615-47-10-879
 [A]  - STUBBE H ET AL, "Polymeric IgA is superior to monomeric IgA and IgG carrying the same variable domain in preventing Clostridium difficile toxin A damaging of T84 monolayers", THE JOURNAL OF IMMUNOLOGY, THE AMERICAN ASSOCIATION OF IMMUNOLOGISTS, INC, US, (20000215), vol. 164, no. 4, ISSN 0022-1767, pages 1952 - 1960, XP009107500 [A] 1-23
 [Y]  - LEIBL H ET AL, "Method for the isolation of biologically active monomeric immunoglobulin A from a plasma fraction", JOURNAL OF CHROMATOGRAPHY B, ELSEVIER SCIENCE PUBLISHERS, NL, (19960412), vol. 678, no. 2, doi:10.1016/0378-4347(95)00501-3, ISSN 0378-4347, pages 173 - 180, XP004044044 [Y] 1-23 * page 173; table 1 *

DOI:   http://dx.doi.org/10.1016/0378-4347(95)00501-3
 [A]  - KABIR S ED - SANCHEZ ANA ET AL, "Jacalin: a jackfruit (Artocarpus heterophyllus) seed-derived lectin of versatile applications in immunobiological research", JOURNAL OF IMMUNOLOGICAL METHODS, ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM, NL, (19980315), vol. 212, no. 2, doi:10.1016/S0022-1759(98)00021-0, ISSN 0022-1759, pages 193 - 211, XP004129932 [A] 1-23

DOI:   http://dx.doi.org/10.1016/S0022-1759(98)00021-0
 [A]  - HAUN M ET AL, "A rapid procedure for the purification of IgA"1 and IgA"2 subclasses from normal human serum using protein G and jackfruit lectin (jacalin) affinity chromatography", IMMUNOLOGY LETTERS, ELSEVIER BV, NL, vol. 22, no. 4, doi:10.1016/0165-2478(89)90165-X, ISSN 0165-2478, (19891001), pages 273 - 279, (19891001), XP023691958 [A] 1-23

DOI:   http://dx.doi.org/10.1016/0165-2478(89)90165-X
 [A]  - MANTIS NICHOLAS J ET AL, "Secretory IgA: Arresting Microbial Pathogens at Epithelial Borders", IMMUNOLOGICAL INVESTIGATIONS, INFORMA HEALTHCARE, US, (20100101), vol. 39, no. 4-5, doi:10.3109/08820131003622635, ISSN 0882-0139, pages 383 - 406, XP009161810 [A] 1-23 * page 386 *

DOI:   http://dx.doi.org/10.3109/08820131003622635
by applicant   - KELLY, CPLAMONT, JT, N Engl J Med, (20080000), vol. 359, pages 1932 - 40
    - BARTLETT, JG et al., N Engl J Med, (19780000), vol. 298, pages 531 - 4
    - MILLER, BA et al., Infect Control Hosp Epidemiol, (20110000), vol. 32, pages 387 - 90
    - Int J Antimicrob Agents, (20090000), vol. 33, no. 1, pages 1 - 56
    - KUIJPER EJ et al., Clin Microbiol Infect, (20060000), vol. 12, no. 6, pages 2 - 18
    - SURAWICZ, CMALEXANDER, J., Nat Rev Gastroenterol Hepatol, (20110000), vol. 8, pages 330 - 9
    - LOWY, I. et al., N Engl J Med, (20100000), vol. 362, pages 197 - 205
    - PHALIPON A et al., Immunity, (20020000), vol. 17, pages 107 - 115
    - CHEN et al., Gastroenterology, (20080000), vol. 135, pages 1984 - 92
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.